2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis | 강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
2009 | | A case of bladder rhabdomyosarcoma in an adult | 강석윤, 김세중, 주희재, 최용원 |
2010 | | A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation | 강석윤, 박준성, 이현우, 정선용, 정성현, 최진혁, 한재호 |
2009 | | A case of head and neck rhabdomyosarcoma with pancreatic metastasis | 강석윤, 안미선, 최용원, 한재호 |
2005 | | A Case of Lymphomatoid Papulosis after Allogenic Bone Marrow Transplatation | 강석윤, 김효철, 박준성, 이은소, 이현우, 임호영, 장준호, 최진혁 |
2009 | | A Case Report of Helicobacter Pylori Negative Gastric MALT Lymphoma with Monoclonal Gammopathy | 강석윤, 김명욱, 김장희, 박준성, 유병무, 이현우, 정성현, 최진혁, 한재호 |
2016 | | A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting | 강석윤 |
2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
2011 | | A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database | 감혜진, 강석윤, 박래웅, 박인휘, 이기영 |
2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
2017 | | A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer | 강석윤 |
2019 | | Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression | 강석윤, 김장희, 박태준, 최용원 |
2012 | | Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report | 강석윤, 박준성, 안미선, 이현우, 정성현, 최진혁 |
2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
2007 | | Aging Effects on Dendritic Cells after Total Body Irradiation in Mice | 강석윤, 김효철, 박준성, 이현우, 정성현, 최진혁 |
2018 | | Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study | 강석윤, 이현우 |
2011 | | Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | 강석윤, 김장희, 박준성, 신승수, 안미선, 이광재, 이현우, 정성현, 최진혁, 한재호 |
2016 | | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer | 강석윤 |
2009 | | Clinical Significance of Co-expression of Aberrant Antigens in Acute Leukemia | 강석윤, 김효철, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia. | 강석윤, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
2000 | | Clinical significance of skin test and specific IgE measurement for the prediction of immediate type hypersensitivity reaction to horse antithymocyte globulin | 강석윤, 김선신, 김효철, 남동기, 남동호, 박해심, 서유진 |
2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
2013 | | Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer. | 강두경, 강석윤, 김구상, 김지영, 김태희, 박래웅, 안미선, 안영실, 임현이, 전자영, 정용식 |
2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments | 강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환 |
2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
2009 | | Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer | 강석윤, 박광주, 신승수, 안미선, 오영택, 이현우, 정성현, 최진혁 |
2009 | | Difference in Viability of CD34+ Cells in Cryopreserved Cord Blood According to Evaluation Methods | 강석윤, 김효철, 박준성, 이현우, 정성현, 최진혁 |
2012 | | Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis | 강두경, 강석윤, 김구상, 김태희, 박래웅, 안영실, 오기근, 임현이, 전미선, 정용식 |
2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
2018 | | Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy | 강석윤 |
2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2007 | | Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. | 강석윤, 김효철, 박준성, 이현우, 최진혁 |
2001 | | Factors Affecting Mobilization and Engraftment in High Dose Chemotherapy with Fixed Dose of Glycosylated rHuG-CSF(Lenograstim) | 강석윤, 김효철 |
2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
2013 | | Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. | 강석윤, 김장희, 박태준, 임현이, 정용식 |
2013 | | Granulocytic sarcoma in breast after bone marrow transplantation. | 강두경, 강석윤, 김구상, 김태희, 임현이, 정성현, 정용식 |
2012 | | Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection | 강석윤, 김영배, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최진혁, 한상욱, 한재호 |
2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy | 강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2021 | | Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, her2-negative metastatic breast cancer: Subgroup analyses of kcsg-br15-10 (youngpearl) | 강석윤 |
2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호 |
2012 | | Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity | 강두경, 강석윤, 김구상, 김태희, 임현이, 정용식 |
2015 | | Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer. | 강석윤 |
2017 | | Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients | 강석윤 |
2013 | | Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). | 강석윤 |
2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2009 | | Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy | 강석윤, 강승희, 오영택, 전미선, 최진혁 |
2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2019 | | Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) | 강석윤 |